Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.
about
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patientFundamentals of aerosol therapy in critical careThe use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic reviewColistin for lung infection: an updateNebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysisInhaled Antibiotics for Gram-Negative Respiratory InfectionsBiopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. ColistinColistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients.Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellaneaComparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective studyEffects of Emulsion Composition on Pulmonary Tobramycin Delivery During Antibacterial Perfluorocarbon Ventilation.Multidrug-resistant Gram-negative infections: the use of colistin.Pharmacokinetic evaluation of colistin sodium.Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.The strategy of antibiotic use in critically ill neutropenic patientsInhaled colistin for lower respiratory tract infections.Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update.Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.National Survey of Thai Infectious Disease Physicians on Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: The Role of Infection Control Awareness.Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia.Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.Pulmonary Pharmacokinetics of Colistin Following Administration of Dry Powder Aerosols in Rats.Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges.Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study.Aerosol delivery during invasive mechanical ventilation: a systematic review.BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients.Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis.Mechanism-based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model.
P2860
Q26752680-7EB280C6-2263-4A05-89E0-0EE68FB13326Q28068836-5A7A609F-74B6-4345-B1F1-6D3D8AC5E654Q28080123-69174A56-05B3-4102-A50F-E61E1C7972C7Q28082041-803A2C54-EC88-4EF8-B9D3-224664E27E52Q28084615-66A1E918-BED9-4714-B300-B591BBD062F7Q28386160-23E8DAD2-4833-423B-93C9-E3A0F162887BQ33798554-89841906-0B9C-4D52-A9F9-A407F152661FQ34015375-69E0D01B-B30F-4147-80D6-2C8032CC92DBQ34533628-E529788B-F5D8-43C4-B75A-FC2555CD9C56Q34597749-271EE3C4-9D22-465B-AA8E-EB4AEA7D8F19Q34922728-DC3F9853-35DD-45B5-A9BD-1918E2A98FC0Q35052517-E32C14F2-B797-4AF6-B7D3-6B1D1F8148E2Q36971632-8195510E-03B7-4E3C-A510-AC990E266EACQ37785545-2E5B286F-F97B-43EC-82DE-5DD3C6D7C11AQ37815508-F54812A8-9EE3-4D89-8CCA-25D38CC0095BQ37910022-43BDB9F7-3787-40C0-93EF-CF13E94BBCD2Q37929895-7384DFC3-30A0-4CDD-B321-BF18125DAEDDQ37983920-270A6AE8-20C2-45BA-9D01-C8FEFE8A6A94Q38102781-4FEF0052-133A-48DB-B899-60D7CAC2C2F1Q38210320-EB04CC8D-6F00-4CD9-9891-1DB1F234CC6FQ38383811-59779E26-9898-4A7B-BF15-84CA519D2276Q38394222-532688CE-1587-45C4-87B6-86A374051FB4Q38647453-F4197C7F-63A9-4A83-ACF0-94572FF4942DQ38672016-C08D624D-BE97-45A8-9A6F-C259934A27DEQ38755683-66879A10-018D-481F-84DA-1F33E319856FQ38783043-EF297F92-6C4D-4A24-90E3-28F151124E6DQ38944862-93467781-CA97-4194-832A-AD1D24E23FACQ39057108-1336B1A2-89D3-4D91-854C-C308C2A0F478Q40093588-EBFD621E-E12D-47A1-B9B8-C6A849B48245Q40422166-FCF77B26-A987-44A3-93C0-9424C91D956CQ40657458-8C82749A-2007-4C01-A76E-ACCF119BE467Q41027375-344D6C62-D05C-4193-9496-6F7AC178DC98Q41260939-176EC29C-A727-4078-A7A1-3EBCD50E6E71Q41453012-9C28280F-D42D-4F2F-B2BA-085E6E7F0EC7Q41896136-50D7C3F4-C795-4017-8361-004A8E2429BCQ42654272-1F3B32C3-3DDE-4022-B9AC-D33A0BC70789Q43700878-DE9ED3A2-0CF1-4381-A0BE-6DABE9A98274Q44210071-C4C55E9A-1ED9-4F49-AF6B-A2F095596A92Q45930199-6F2E6B15-243D-42BD-B849-2AF337BD9205Q47273930-B15A0D2D-99CE-40E2-91E7-2CE498A17618
P2860
Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@en
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@nl
type
label
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@en
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@nl
prefLabel
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@en
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@nl
P2093
P2860
P1476
Nebulized and intravenous coli ...... sed by Pseudomonas aeruginosa.
@en
P2093
Belaïd Bouhemad
Cassio Girardi
Charles-Hugo Marquette
Frédéric Wallet
Gilles Le Naour
Jean-Jacques Rouby
Kamel Louchahi
Marie-Helene Becquemin
Olivier Petitjean
P2860
P2888
P304
P356
10.1007/S00134-010-1879-4
P577
2010-04-16T00:00:00Z